Neogen Chemicals Complete Financial Statements
In FY2026, Neogen Chemicals (NEOGEN) reported revenue ₹248 Cr, net profit ₹11 Cr and EPS ₹4.32, with a net profit margin of 4.4% and ROE of 1.3%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see NEOGEN share price.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
NEOGEN Revenue, Net Profit & EBITDA — Year-on-Year Growth
NEOGEN YoY (Mar 2025 vs Mar 2026) — revenue +21.6%, net profit +450.0%, EBITDA +95.7%, expenses +12.2%. Explore Neogen Chemicals intrinsic worth to estimate fundamental worth using multiple valuation models.
NEOGEN Income Statement — Revenue, EBITDA & Net Profit
Neogen Chemicals revenue ₹248 Cr, EBITDA ₹45 Cr, net profit ₹11 Cr, EPS ₹4.32 (2026) — net profit margin 4.4%. Review Neogen Chemicals P/E valuation to evaluate earnings-based valuation against sector peers.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 248 | 211 | 204 | 188 | 222 | 194 | 202 | 182 | 203 | 164 | 206 | 167 | 166 | 149 | 158 | 149 | 188 | 113 | 93 | 85 | 133 | 82 | 82 | 77 | 85 | 77 | 80 | 65 | 82 | 58 | 39 | 64 |
| Expenses | 203 | 179 | 181 | 155 | 188 | 159 | 164 | 149 | 167 | 136 | 171 | 137 | 144 | 124 | 130 | 123 | 156 | 93 | 74 | 69 | 109 | 67 | 67 | 63 | 68 | 62 | 64 | 53 | 66 | 47 | 32 | 53 |
| EBITDA | 45 | 32 | 23 | 33 | 34 | 35 | 38 | 32 | 36 | 28 | 34 | 30 | 22 | 25 | 28 | 26 | 32 | 21 | 19 | 16 | 24 | 16 | 16 | 14 | 17 | 15 | 16 | 12 | 16 | 10 | 7 | 11 |
| Operating Profit Margin % | 18.00% | 14.00% | 11.00% | 17.00% | 15.00% | 18.00% | 18.00% | 17.00% | 17.00% | 16.00% | 16.00% | 17.00% | 12.00% | 16.00% | 17.00% | 17.00% | 16.00% | 18.00% | 20.00% | 18.00% | 18.00% | 19.00% | 19.00% | 18.00% | 20.00% | 19.00% | 20.00% | 18.00% | 19.00% | 17.00% | 17.00% | 16.00% |
| Depreciation | 8 | 7 | 7 | 6 | 7 | 7 | 6 | 7 | 7 | 6 | 4 | 6 | 6 | 4 | 4 | 4 | 4 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 22 | 20 | 13 | 13 | 22 | 13 | 10 | 10 | 13 | 11 | 9 | 11 | 11 | 7 | 5 | 6 | 7 | 4 | 4 | 4 | 6 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit Before Tax | 16 | 5 | 4 | 14 | 6 | 16 | 23 | 16 | 15 | 11 | 21 | 14 | 6 | 14 | 19 | 16 | 21 | 14 | 13 | 10 | 14 | 10 | 11 | 9 | 12 | 11 | 12 | 8 | 12 | 7 | 4 | 7 |
| Tax | 5 | 2 | 1 | 4 | 2 | 5 | 6 | 4 | 5 | 3 | 6 | 4 | 5 | 4 | 3 | 5 | 6 | 3 | 4 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 4 | 2 | 3 | 2 | 1 | 3 |
| Net Profit | 11 | 3 | 2 | 10 | 4 | 11 | 17 | 12 | 10 | 8 | 14 | 10 | 1 | 10 | 16 | 11 | 15 | 11 | 9 | 7 | 11 | 7 | 7 | 6 | 9 | 8 | 9 | 5 | 8 | 5 | 3 | 4 |
| Earnings Per Share (₹) | 4.32 | 1.28 | 0.91 | 3.89 | 1.40 | 4.15 | 6.42 | 4.35 | 3.80 | 3.17 | 5.74 | 3.90 | 0.41 | 3.95 | 5.50 | 4.45 | 5.89 | 4.79 | 3.99 | 3.15 | 4.49 | 3.16 | 3.13 | 2.62 | 3.66 | 3.21 | 4.36 | 2.32 | 3.46 | 0.00 | 1.43 | 2.17 |
NEOGEN Balance Sheet — Assets, Liabilities & Shareholders' Equity
NEOGEN total assets ₹2,902 Cr, total equity ₹816 Cr, total liabilities ₹ Cr (2026) — ROE 1.3%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Total Assets | 2,902 | 1,747 | 1,461 | 1,054 | 799 | 492 | 355 | 246 | 180 |
| Current Assets | 1,393 | 1,000 | 784 | 656 | 493 | 240 | 231 | 160 | 107 |
| Fixed Assets | 1,332 | 404 | 496 | 348 | 285 | 127 | 111 | 83 | 67 |
| Capital Work in Progress | 857 | 156 | 109 | 36 | 11 | 115 | 3 | 0 | 1 |
| Investments | 568 | 0 | 0 | 77 | 82 | 1 | 1 | 1 | 0 |
| Other Assets | 0 | 1,187 | 856 | 594 | 422 | 250 | 241 | 163 | 112 |
| LIABILITIES | |||||||||
| Total Liabilities | |||||||||
| Current Liabilities | 898 | 225 | 174 | 162 | 142 | 131 | 49 | 60 | 46 |
| Non-Current Liabilities | |||||||||
| SHAREHOLDERS' EQUITY | |||||||||
| Total Equity | 816 | 789 | 760 | 483 | 439 | 183 | 156 | 70 | 50 |
| Share Capital | 26 | 26 | 26 | 25 | 25 | 23 | 23 | 20 | 20 |
| Reserves & Surplus | 790 | 763 | 734 | 458 | 414 | 160 | 133 | 50 | 30 |
NEOGEN Cash Flow Statement — Operating, Investing & Financing
Neogen Chemicals operating cash flow ₹196 Cr, investing ₹-317 Cr, financing ₹113 Cr, net cash flow ₹-8 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 196 | -29 | -30 | 1 | 84 | -35 | -4 | 12 | 0 | 9 | 9 |
| Investing Activities | -317 | -216 | -95 | -146 | -135 | -29 | -20 | -13 | -33 | -4 | -2 |
| Financing Activities | 113 | 237 | 100 | 188 | 51 | 63 | 24 | 0 | 33 | -4 | -6 |
| Net Cash Flow | -8 | -8 | -25 | 44 | 0 | -1 | 0 | -1 | 1 | 0 | 1 |